期刊文献+

肝素结合性表皮生长因子与动脉粥样硬化关系的研究进展 被引量:3

Research Progress of Association of Heparin-binding Epidermal Growth Factor with Atherosclerosis
下载PDF
导出
摘要 肝素结合性表皮生长因子(HB-EGF)是表皮生长因子家族中重要的一员,参与许多病理生理过程,具有促进细胞增殖、迁移、分化及信号转导等作用,与动脉粥样硬化(As)的形成密切相关,在泡沫细胞的形成、单核巨噬细胞的迁移、血管平滑肌细胞的功能发挥等过程中具有重要的作用,能够促进As的形成,与冠心病的发生密切相关,且可能有促进冠心病的发生、促进冠状动脉粥样斑块形成等作用;HB-EGF亦能够促进神经损伤的恢复,促进神经胶质细胞再生,与缺血性脑血管病密切相关。 Heparin-binding epidermal growth factor(HB-EGF) is an important member of the epidermal growth factor family. HB-EGF is involved in many pathophysiological processes, which can promote cell proliferation, migration, differ- entiation and signal transduction, and is closely related to the atherosclerosis (As) formation. HB-EGF may play an important role in the process in the formation of foam cells, mononuelear macrophage migration and the function of the vascular smooth muscle cells, it can promote the as formation. HB-EGF is closely related to the occurrence of coronary heart disease, and may promote the occurrence of coronary heart disease, promote coronary artery atheromatous plaque formation, and so on; HB-EGF can promote the recovery of nerve injury, also promote the glial cell regeneration, which is closely associated with isehemie cerebrovaseular disease.
作者 李强 唐伯儒 丛树艳 LI Qiang TANG Boru CONG Shuyan.(Department of Neurology, Shengjing Hospital of China Medical University, Shenyang 110004, China)
出处 《医学综述》 2017年第8期1461-1465,共5页 Medical Recapitulate
基金 国家自然科学基金(81371271)
关键词 动脉粥样硬化 冠心病 脑梗死 肝素结合性表皮生长因子 Atherosclerosis Coronary heart disease Cerebral infarction Heparin-binding epidermal growth factor
  • 相关文献

参考文献4

二级参考文献27

  • 1Alberto Dominguez-Rodriguez,Gabriela Blanco-Palacios,Pedro Abreu-Gonzalez.Increased heart rate and atherosclerosis: Potential implications of ivabradine therapy[J].World Journal of Cardiology,2011,3(4):101-104. 被引量:14
  • 2黄进,汤涌,贾海波,刘志忠,陈绍良,杜同心.血清叶酸与冠状动脉支架内再狭窄关系的研究[J].中国心血管病研究,2005,3(3):194-195. 被引量:3
  • 3张均田.现代药理实验方法,第一版[M].北京:北京医科大学协和医科大学联合出版社,1998,1.266-268.
  • 4Prati F, Imola F, Corvo P, et al. The restart project : high-dose atorvast atin helps control restenosis after stenting procedures at high risk for restenosis. Results from a prospective study and a matched control group comparison [ J ]. Euro Intervention, 2007,3 ( 1 ) : 89 -94.
  • 5Mercado N, Boerrsma E, Wijins W. Clinical and quantitative Coronary angiographic predictors of coronary restenosis : a comparative analysis from the balloon-to-stentera [ J ]. J AM coll cardiol, 2001,38 ( 3 ) : 645- 652.
  • 6Zhang H, Sunnarborg SW, McNaughton KK, et al. Heparinbinding epi- dermal growth factor like growth factor dignaling in flow induced arteri- al remodeling[J]. Circ Res,2008,102(10) :1275-125.
  • 7Matsumoto S, Kishida K, Shimomura I, et al. Increased plasma HB- EGF associated with obsesity and coronary artery disease[ J]. Biochem Biophys Res Commun,2002,292(3) :781-786.
  • 8Mukai E, Kume N, Hayashida K, et al. Heparin-binding EGF-like growth factor induces expression of lectin-like oxidized LDL receptor- 1 in vascular smooth muscle cells [ J]. Atherosclerosis, 2004, 176 (2) :289-296.
  • 9Chen X, Ren 5, Ma M G, et al.Hirulog-Iike peptide reduces restenosis and expression of tissue factor and transforming growth factor=B in carotid artery of atherosclerotic rabbits[J].Atherosclerosis, 2003, 169 ( 1 ): 31-40.
  • 10Yuan 5 M, Jing H.Cardiac pathologies in relation to Smad-dependent pathways[J].Interact Cardiovasc Thorae Surg, 2010, 11 (4): 455- 460.

共引文献12

同被引文献37

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部